Discover 1,161 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,161
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
for
Cancer
Location: Norwich CT, Fairhaven MA, East Syracuse NY, Ithaca NY,
Sponsor: Tempus AI
Sex: All
Age: 18 - 70+
Code: NCT06207032
Recruiting
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
for
Transthyretin Amyloidosis With Cardiomyopathy
Location: Norwich CT, Manhasset NY, The Bronx NY, New York NY,
Sponsor: Alnylam Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07052903
Phase 3, Recruiting
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
for
Diabetic Macular Edema (DME)
Location: Greenwich CT, Bloomfield NJ, New York NY, Fairfax VA,
Sponsor: 4D Molecular Therapeutics
Sex: All
Age: 18+
Code: NCT07867080
Phase 3, Recruiting
Dermal Allograft Augmentation of Large and Massive Rotator Cuff Tears
for
Full-thickness Rotator Cuff Tear
Location: Greenwich CT, Nashville TN, Scottsdale AZ, Medford OR
Sponsor: Arthrex, Inc.
Sex: All
Age: 30 - 70+
Code: NCT05981833
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: New Haven CT, Springfield MA, Valhalla NY,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated
for
Diabetic Macular Edema
Location: Waterford CT, Oceanside NY, Falls Church VA,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07553429
Phase 1, Phase 2, Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versus EYLEA® HD (Aflibercept) in Participants With Neovascular Age-related Macular Degeneration
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Location: Waterford CT, Hagerstown MD, West Columbia SC,
Sponsor: Ocular Therapeutix, Inc.
Sex: All
Age: 50+
Code: NCT07516132
Phase 3, Recruiting
Investigation of Egg Intake and the Relationship Between Gut Microbiome, Metabolic, and Immune Profiles
for
Obesity (BMI Equal to or >30), Immune Function, HDL,
Location: Storrs CT
Sponsor: University of Connecticut
Sex: All
Age: 18 - 50
Code: NCT07844616
Recruiting
Synchronous vs Asynchronous Remotely Delivered Lifestyle Interventions
for
Obesity
Location: Storrs CT
Sponsor: University of Connecticut
Sex: All
Age: 18 - 65
Code: NCT06393725
Recruiting
Assessment of Gait Adaptation Due to an Asymmetric Walking Protocol
for
Anterior Cruciate Ligament Reconstruction
Location: Storrs CT
Sponsor: University of Connecticut
Sex: All
Age: 18 - 30
Code: NCT05968729
Recruiting
Cannabidiol Effects on Learning and Anxiety
for
Anxiety and Fear
Location: Storrs CT
Sponsor: University of Connecticut
Sex: All
Age: 18 - 50
Code: NCT05283382
Early Phase 1, Recruiting
Digital Intervention Participation in DASH
for
Hypertension, Dietary Quality, Recruitment,
Location: Storrs CT
Sponsor: University of Connecticut
Sex: All
Age: 18+
Code: NCT04515303
Recruiting
HIV Treatment Adherence Dose Determination Trial
for
HIV Infections
Location: Storrs CT, Atlanta GA
Sponsor: University of Connecticut
Sex: All
Age: 18+
Code: NCT04577313
Recruiting
Effects of Freeze-dried Grape Powder on Immune Profiles in Healthy Aging Adults
for
Healthy Aging, Inflammation
Location: Storrs CT
Sponsor: University of Connecticut
Sex: All
Age: 50 - 70+
Code: NCT07079982
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive